An analysis of the tumor biology of women with HR-positive, HER2-negative early breast cancer uncovered specific genomic alterations enriched in younger women.
Medscape Medical News
Genomic Features Linked to Worse Outcomes in Young BC Patients
An analysis of the tumor biology of women with HR-positive, HER2-negative early breast cancer uncovered specific genomic alterations enriched in younger women.
Medscape Medical News
